Literature DB >> 1689693

Limiting-dilution analysis of the frequency of myelin basic protein-reactive T cells in Lewis, PVG/c and BN rats. Implication for susceptibility to autoimmune encephalomyelitis.

Y Matsumoto1, K Kawai, Y Tomita, M Fujiwara.   

Abstract

Susceptibility to experimental autoimmune encephalomyelitis (EAE), which is an autoimmune disease inducible by immunization with a brain-specific antigen in complete Freund's adjuvant (CFA), is different among strains. In an attempt to resolve the immune mechanisms by which the difference in susceptibility to EAE is regulated, we re-estimated susceptibility of several strains of rats, and the frequency of antigen-reactive T cells in each strain was determined by limiting-dilution analysis. EAE was induced in Lewis (LEW), PVG/c and BN rats using four different methods: (i) active immunization with guinea-pig myelin basic protein (GPBP) in CFA; (ii) immunization with GPBP in CFA that had been further supplemented with Mycobacterium tuberculosis H37Ra (supplemented CFA); (iii) adoptive transfer of GPBP-activated spleen cells into syngeneic rats; and (iv) transfer of a GPBP-specific T-cell line. The LEW strain was susceptible to all four methods. The PVG/c strain was resistant to immunization with GPBP in conventional CFA (GPBP/conv. CFA), but was susceptible to immunization with GPBP in supplemented CFA (GPBP/suppl. CFA) and to transfer of activated spleen cells. The BN strain was resistant to all methods. Limiting-dilution analysis using T cells from LEW, PVG/c or BN rats has revealed that each strain of rat displays a different pattern of frequencies of GPBP-reactive or the 68-88 sequence (GP68-88)-reactive T cells. LEW rats showed relatively high frequencies of GPBP-reactive and GP68-88-reactive T cells after immunization with either GPBP/conv. CFA or GPBP/suppl. CFA, symptomatic rats showing higher values than asymptomatic rats. In asymptomatic PVG/c rats, the frequency of GP68-88-reactive T cells was lower than that of GPBP-reactive T cells. In PVG/c rats with clinical EAE, however, GP68-88-reactive T cells increased in frequency and were almost the same as GPBP-reactive T cells. BN rats, on the other hand, responded very poorly not only to the GP68-88 sequence but also to the whole GPBP molecule, even after immunization with GPBP/suppl. CFA. These findings, obtained by limiting-dilution analysis, strongly suggest that the development of EAE in LEW, PVG/c and BN rats is closely related to the frequency of GPBP-reactive T cells. Furthermore, it is shown that resistance to EAE found in PVG/c and BN rats may be generated by different immune mechanisms.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689693      PMCID: PMC1385592     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  26 in total

1.  Studies on the mechanism of altered susceptibility to experimental allergic encephalomyelitis.

Authors:  S LEVINE; E J WENK
Journal:  Am J Pathol       Date:  1961-10       Impact factor: 4.307

2.  Immunohistochemical analysis of the rat central nervous system during experimental allergic encephalomyelitis, with special reference to Ia-positive cells with dendritic morphology.

Authors:  Y Matsumoto; N Hara; R Tanaka; M Fujiwara
Journal:  J Immunol       Date:  1986-05-15       Impact factor: 5.422

3.  Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.

Authors:  G E Deibler; R E Martenson; M W Kies
Journal:  Prep Biochem       Date:  1972

4.  A myelin basic protein-specific T lymphocyte line that mediates experimental autoimmune encephalomyelitis.

Authors:  A A Vandenbark; T Gill; H Offner
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

5.  In situ detection of class I and II major histocompatibility complex antigens in the rat central nervous system during experimental allergic encephalomyelitis. An immunohistochemical study.

Authors:  Y Matsumoto; M Fujiwara
Journal:  J Neuroimmunol       Date:  1986-10       Impact factor: 3.478

6.  Experimental autoimmune encephalomyelitis mediated by T lymphocyte lines: genotype of antigen-presenting cells influences immunodominant epitope of basic protein.

Authors:  E Beraud; T Reshef; A A Vandenbark; H Offner; R Friz; C H Chou; D Bernard; I R Cohen
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

7.  Genetic control of the development of experimental allergic encephalomyelitis in rats. Separation of MHC and non-MHC gene effects.

Authors:  M P Happ; P Wettstein; B Dietzschold; E Heber-Katz
Journal:  J Immunol       Date:  1988-09-01       Impact factor: 5.422

8.  The immunopathology of adoptively transferred experimental allergic encephalomyelitis (EAE) in Lewis rats. Part 1. Immunohistochemical examination of developing lesions of EAE.

Authors:  Y Matsumoto; M Fujiwara
Journal:  J Neurol Sci       Date:  1987-01       Impact factor: 3.181

9.  Adoptive transfer of murine chronic-relapsing autoimmune encephalomyelitis. Analysis of basic protein-reactive cells in lymphoid organs and nervous system of donor and recipient animals.

Authors:  R J Fallis; M L Powers; M S Sy; H L Weiner
Journal:  J Neuroimmunol       Date:  1987-03       Impact factor: 3.478

10.  Differences in the repertoire of the Lewis rat T cell response to self and non-self myelin basic proteins.

Authors:  M P Happ; E Heber-Katz
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

View more
  3 in total

1.  In situ inactivation of infiltrating T cells in the central nervous system with autoimmune encephalomyelitis. The role of astrocytes.

Authors:  Y Matsumoto; H Hanawa; M Tsuchida; T Abo
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

2.  T cells in the lesion of experimental autoimmune encephalomyelitis. Enrichment for reactivities to myelin basic protein and to heat shock proteins.

Authors:  F Mor; I R Cohen
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

3.  Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.

Authors:  Y Matsumoto; M Tsuchida; H Hanawa; T Abo
Journal:  Immunology       Date:  1994-01       Impact factor: 7.397

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.